Otlang, Aimee .

HRN: 23-95-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
CEFUROXIME 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
BID
THICKLY MSAF
Checking Final Appropriateness 
10/24/2023
METRONIDAZOLE 500MG (TAB)
10/24/2023
10/30/2023
PO
500mg
TID
THICKLY MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: